Rachel E T Bentley Selected Research

N'- (7- fluoroH- pyrrolo(1,2- a)quinoxalin- 4- yl)pyrazine- 2- carbohydrazide

1/2022

Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rachel E T Bentley Research Topics

Disease

3	Hypoxia (Hypoxemia) 01/2022 - 01/2021
1	Fibrosis (Cirrhosis) 01/2022
1	Cardiotoxicity 01/2022
1	Hypertrophy 01/2022
1	Vascular Diseases (Vascular Disease) 01/2022
1	Pulmonary Hypertension 01/2021
1	Neoplasms (Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

2	Oxygen (Dioxygen)IBA 01/2021 - 01/2021
1	N'- (7- fluoroH- pyrrolo(1,2- a)quinoxalin- 4- yl)pyrazine- 2- carbohydrazideIBA 01/2022
1	Semaxinib (SU5416)IBA 01/2022
1	Atrial Natriuretic Factor (ANF)IBA 01/2022
1	MonocrotalineIBA 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	InflammasomesIBA 01/2022
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	Dynamins (Dynamin)IBA 01/2021
1	EnzymesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021

Therapy/Procedure

1	Therapeutics 01/2021